Pfizer will invest another $500 million in the expansion of its manufacturing facility in North Carolina, which could help advance hemophilia treatments.
Pfizer will invest another $500 million in the expansion of its manufacturing facility in North Carolina, which could help advance hemophilia treatments.
No comments:
Post a Comment